New York (Feb. 1, 2010)—Pfizer Animal Health is releasing the next scenario for the “Virtual Walk the Pens” simulator. The simulator is an online educational tool that can be played from any standard computer and is intended to help demonstrate the importance of Individual Pig Care.
In the ninth scenario, players must walk the virtual barn to determine if the loose stool reported by another caretaker is cause for concern. As always, the virtual veterinarian is on hand to help advise players in this scenario.
“As the scenarios have progressed we’ve been very impressed with the knowledge and expertise displayed by participants,” says Eric Farrand, Pig Husbandry Team Manager, Pfizer Animal Health. “We hope that each scenario provides a new and challenging opportunity to further improve their training in Individual Pig Care.”
Since June 2009, 2442 players have gone to work in the virtual barn to determine the best course of action for the 2,400 virtual pigs. Each month, the highest ranking player will receive an Individual Pig Care tool belt to help make work in the real barns a little easier. All of the scenarios to-date and player rankings can be found at www.individualpigcare.com/WTPGame.
Individual Pig Care™ is an approach that provides for pig needs to maximize potential, producer needs for increased profitability and societal needs for a sustainable, high-quality product, raised with sound husbandry practices.
Pfizer Inc. (NYSE: PFE), the world’s largest research-based pharmaceutical company, is a world leader in discovering and developing innovative animal vaccines and prescription medicines. Pfizer Animal Health is dedicated to improving the safety, quality and productivity of the world’s food supply by enhancing the health of livestock and poultry; and in helping companion animals live longer and healthier lives. For additional information on Pfizer Animal Health’s portfolio of animal products, visit www.PfizerAH.com.
# # #
All brands are the property of Pfizer Inc., its affiliates and/or its licensors. ©2009 Pfizer Inc. All rights reserved GSW09076
News Media Contact: